Journalism of Courage
Premium

JP Nadda: Deliberating on Johnson & Johnson issue

Six months after an expert committee recommended that Johnson & Johnson give Rs 20 lakh as compensation to each patient affected by “faulty” hip implants sold by its subsidiary, the Union Health Ministry is yet to take a call on the matter.

Vibrant Gujarat, Vibrant Gujarat Summit, healthcare and pharmaceuticals, J P Nadda, shaping a New paradigm in Medical & Pharma Service, Indian Express Union Health Minister J P Nadda will preside over the seminar titled ‘Shaping a New Paradigm in Medical & Pharma Services’. (Express Photo by Prem Nath Pandey/File)
Advertisement

Six months after an expert committee recommended that Johnson & Johnson give Rs 20 lakh as compensation to each patient affected by “faulty” hip implants sold by its subsidiary, the Union Health Ministry is yet to take a call on the matter.

Replying to a question on the committee’s report that was not made public, Health Minister J P Nadda said: “We are deliberating on the matter and will come back soon.”

The findings of the expert committee, reported in The Indian Express, constitute the first official indictment in India against J&J, which imported and sold ASR XL Acetabular Hip System and ASR Hip Resurfacing System in the country — these devices were globally recalled in 2010.

Curated For You
India U19 vs Pakistan U19 Live Cricket Score, Asia Cup 2025 Final: IND lose final to PAK by 191 runs
Dhurandhar Box Office Collection Day 16 Update: Ranveer Singh film earns over Rs 36 cr on Sunday
Bigg Boss Telugu Season 9 Winner LIVE Updates: Emmanuel exits Nagarjuna’s show

Stay updated with the latest - Click here to follow us on Instagram

Tags:
  • JP Nadda
Edition
search
Install the Express App for
a better experience
Featured
Today's E-paper
Dec 21, 2025
Trending Topics
News
Multimedia
Follow Us
Tavleen Singh writesWhy this Christmas season makes me nostalgic for the old India
X